﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>27</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>12</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Clinical Profile and Outcomes of Pulmonary Embolism in Central Iran: A Retrospective Cohort Study</ArticleTitle>
    <FirstPage>667</FirstPage>
    <LastPage>673</LastPage>
    <ELocationID EIdType="doi">10.34172/aim.31907</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Andishmand</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4891-0153</Identifier>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Sharifi</LastName>
      </Author>
      <Author>
        <FirstName>Seyedeh Mahdieh</FirstName>
        <LastName>Namayandeh</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/aim.31907</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>08</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>02</Day>
      </PubDate>
    </History>
    <Abstract>Background: Pulmonary embolism (PE) is a significant public health concern. This retrospective cohort study examines the clinical profiles and outcomes of patients diagnosed with PE at a medical center in central Iran, aiming to identify mortality predictors during hospitalization and follow-up. Methods: Data from 109 patients diagnosed with PE were analyzed, with a median follow-up of 23 months. The collected information included demographic and clinical characteristics, laboratory findings, treatment protocols, and outcomes. Logistic regression and Kaplan-Meier survival analysis were used to identify independent mortality predictors and assess survival impact. Results: The mean age was 59.2 years (±19.7), with 51.4% male. Common symptoms included dyspnea (86%) and chest pain (53%), with non-massive PE being the most prevalent (63%). Independent mortality predictors identified were age (odds ratio [OR] 1.065 per year, P&lt;0.001), female sex (OR 4.421, P=0.009), and PE severity (OR 0.262, P=0.023). Kaplan-Meier analysis showed reduced survival probabilities in females (P=0.009), those with provoked PE (P=0.002), patients over 65 (P=0.016), and individuals with comorbidities (P=0.018). In-hospital mortality was 10.1%, linked to provoked massive PE, absence of thrombolytic therapy, and reduced left ventricular ejection fraction (LVEF). Conclusion: In this cohort, age, sex, and PE severity were significant mortality predictors, while provoked PE, advanced age, and comorbidities were associated with lower mid-term survival probabilities.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Mortality</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pulmonary embolism</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Thrombolytic therapy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Venous thromboembolism</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>